Eileen Wrabel
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Oncology 10
- HER2/EGFR in Cancer Research 6
- Cancer Treatment and Pharmacology 2
- Lung Cancer Research Studies 2
- Colorectal Cancer Treatments and Studies 1
-
- Advanced Breast Cancer Therapies 6
- Co-authors
- Ian E. Krop (5 shared papers)Otto Metzger (6 shared papers)Laura M. Spring (4 shared papers)Lorenzo Trippa (2 shared papers)Giuseppe Viale (4 shared papers)Vandana G. Abramson (3 shared papers)Denise A. Yardley (5 shared papers)Aditya Bardia (3 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Cancer Research (2 papers)Tissue Barriers (1 paper)Clinical Cancer Research (1 paper)ESMO Open (1 paper)
- Partner nations
- United StatesItalyAustralia
In The Last Decade
Eileen Wrabel
11 papers receiving 282 citations
Peers
Comparison fields: 5 of 40
- Oncology 222
- Radiology, Nuclear Medicine and Imaging 142
- Cancer Research 74
- Genetics 23
- Structural Biology 3
Countries citing papers authored by Eileen Wrabel
This map shows the geographic impact of Eileen Wrabel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen Wrabel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen Wrabel more than expected).
Fields of papers citing papers by Eileen Wrabel
This network shows the impact of papers produced by Eileen Wrabel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen Wrabel. The network helps show where Eileen Wrabel may publish in the future.
Co-authors
The 25 scholars most cited alongside Eileen Wrabel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 148 | |
| 2 | 2019 | 67 | |
| 3 | 2024 | 20 | |
| 4 | 2014 | 20 | |
| 5 | 2024 | 15 | |
| 6 | 2025 | 5 | |
| 7 | 2024 | 4 | |
| 8 | 2025 | 3 | |
| 9 | 2024 | 2 | |
| 10 | 2023 | 2 | |
| 11 | 2024 | 1 | |
| 12 | 2025 | 0 | |
| 13 | 2025 | 0 |
About Eileen Wrabel
Eileen Wrabel is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 13 papers that have together received 287 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), Advanced Breast Cancer Therapies (6 papers), Breast Cancer Treatment Studies (4 papers), Cancer Treatment and Pharmacology (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Lung Cancer Research Studies (2 papers) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Oncology (222 citations), Radiology, Nuclear Medicine and Imaging (142 citations), Cancer Research (74 citations), Genetics (23 citations) and Structural Biology (3 citations). Eileen Wrabel has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Ian E. Krop, Otto Metzger, Laura M. Spring, Lorenzo Trippa, Giuseppe Viale, Vandana G. Abramson, Denise A. Yardley, Aditya Bardia, Kornélia Polyák and Eric P. Winer. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Tissue Barriers, Clinical Cancer Research and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.